Fairfield, Bush & Co. Moderna, Inc. Transaction History

Fairfield, Bush & Co.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $922,488 - $1.34 Million	6,800 New	6,800 $1.04 Billion
Q4 2021 Feb 09, 2022	SELL	$225.82 - $368.51 $1.08 Million - $1.77 Million	-4,800 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$221.9 - $484.47 $1.07 Million - $2.33 Million	4,800 New	4,800 $1.85 Million
Q2 2021 Aug 02, 2021	SELL	$129.91 - $234.98 $519,640 - $939,920	-4,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $262,960 - $679,440	4,000 New	4,000 $417,000
Q3 2020 Nov 18, 2020	SELL	$54.34 - $94.85 $217,360 - $379,400	-4,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $118,680 - $320,000	4,000 New	4,000 $257,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

Stay updated on Fairfield, Bush & Co. with notifications on news.